MedPath

Alfuzosin Hydrochloride

These highlights do not include all the information needed to use Alfuzosin Hydrochloride safely and effectively. See full prescribing information for Alfuzosin Hydrochloride. Alfuzosin Hydrochloride (Alfuzosin Hydrochloride) TABLET for ORAL use.Initial U.S. Approval: 2003

Approved
Approval ID

8704702e-0889-4a47-9a92-588a8d72d503

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2012

Manufacturers
FDA

Camber Pharmaceuticals

DUNS: 826774775

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alfuzosin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code31722-302
Application NumberANDA090284
Product Classification
M
Marketing Category
C73584
G
Generic Name
Alfuzosin Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 18, 2012
FDA Product Classification

INGREDIENTS (6)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
GUAR GUMInactive
Code: E89I1637KE
Classification: IACT
ALFUZOSIN HYDROCHLORIDEActive
Quantity: 10 mg in 1 1
Code: 75046A1XTN
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alfuzosin Hydrochloride - FDA Drug Approval Details